You can buy or sell CALA and other stocks, options, ETFs, and crypto commission-free!
Calithera Biosciences, Inc. engages in discovering and developing small molecule drugs that that target novel and critical metabolic pathway in tumor and cance-fighting immune cells. It offers programs such as Pipeline, Glutaminase Inhibitor, and Arginase Inhibitor. Read More The company was founded by James A. Wells and Susan M. Molineaux on March 9, 2010 and is headquartered in South San Francisco, CA.
South San Francisco, California
52 Week High
52 Week Low
Expected Nov 6, After Hours